CRISPR makes prostate cancer vulnerable to immunotherapy

Prostate cancer is notoriously difficult to treat with immunotherapy, a type of cancer treatment that helps the immune system identify and destroy tumors. Now, researchers have developed an experimental RNA targeting technology that may make prostate tumors far more vulnerable to an immune…

Continue Reading

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *